Philadelphia, PA Joint Commission

Malvern Behavioral Health

Founded

1948

Program Length

10 days

Focus

This center treats mental health conditions and co-occurring substance use. You receive collaborative, individualized treatment that addresses both issues for whole-person healing.

Malvern Behavioral Health is a Joint-Commission accredited inpatient facility dedicated to treating mental health needs of young adults and adults in Philadelphia. They offer a variety of specialized programs tailored to meet the unique needs and mental health challenges faced by diverse groups. Malvern is dedicated to creating a safe environment where clients are empowered to drive their own path to recovery. Their approach allows all clients to explore and understand their mental health in a supportive setting. Malvern Behavioral Health offers 3 specialized programs, tailored to address specific mental health needs. The Lotus Program is a young adult mental health program for clients aged 18-26. This program addresses conditions such as anxiety, depression, trauma, suicidal ideation, and co-occurring substance use disorders while taking into consideration the stressors most commonly faced by this age group. The Wisteria Program caters to the needs of LGBTQ+ clients. This program addresses the psychological and emotional distress by examining how identifying as LGBTQ+ can impact one's health and wellness in a society that is not accepting. This program is designed to be a safe and affirming space for healing. The Sage Program is a comprehensive mental health and co-occurring disorder program that uses cognitive behavioral therapy (CBT), psychoeducation, mindfulness and movement activities and relapse prevention counseling to help clients recover.

Services

Key offerings grouped by category

Type of Care

Mental health treatment

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Hospital inpatient/24-hour hospital inpatient

Facility Type

Separate inpatient psychiatric unit of a general hospital

Pharmacotherapies

Chlorpromazine Fluphenazine Haloperidol Perphenazine Thiothixene Aripiprazole Brexpiprazole Cariprazine Clozapine Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Treatment Approaches

Activity therapy Cognitive behavioral therapy Dialectical behavior therapy Group therapy Integrated Mental and Substance Use Disorder treatment Individual psychotherapy Abnormal involuntary movement scale

Facility Operation (e.g., Private, Public)

Private for-profit organization

Payment/Insurance/Funding Accepted

Medicare Medicaid Federal military insurance (e.g., TRICARE) Private health insurance Cash or self-payment U.S. Department of VA funds

Special Programs/Groups Offered

Young adults Seniors or older adults Clients with co-occurring mental and substance use disorders Clients who have experienced trauma Persons with post-traumatic stress disorder (PTSD) Persons 18 and older with serious mental illness (SMI)

Assessment/Pre-treatment

Screening for tobacco use

Testing

Laboratory testing

Facility Smoking Policy

Smoking not permitted

Age Groups Accepted

Young Adults Seniors

Facility Vaping Policy

Vaping not permitted

Contact Information

Address

1930 South Broad Street, 4th Floor, Philadelphia, PA, 19145

Phone

(610) 546-0287

Contact

Call